<p>The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims &amp; Hers for its $49 weight-loss pill, including restricting access to the drug&#8217;s ingredients and referring the company to the Department of Justice for potential violations of federal law.</p>
<p>Federal action to limit the production of compounded drugs would be a win for Novo Nordisk, which has been losing share in the weight-loss market to rival Eli Lilly and telehealth firms like Hims. However, the FDA did not make clear whether it could quickly halt the sale of Hims&#8217; product, the cheapest GLP-1 therapy on the U.S. market.</p>
<p>Shares of Hims fell 14.1% in after-hours trade.</p>
<p>The FDA said it plans to restrict GLP-1 ingredients used in non-approved compounded drugs that companies such as Hims and other compounding pharmacies have marketed as alternatives to authorized treatments. The agency cited concerns over quality, safety and potential violations of federal law.</p>
<p>On Thursday, Reuters was first to report that Hims would begin offering copies of Novo Nordisk&#8217;s new Wegovy pill at an introductory price of $49 per month, about $100 less than the brand name.</p>
<p>Novo Nordisk later said it would take legal action against the telehealth company over its plan to sell compounded copies of the drug.</p>
<p>The U.S. Department of Health and Human Services&#8217; General Counsel, Mike Stuart, also said on Friday he has referred Hims &amp; Hers to the Department of Justice for investigation over potential violations.</p>
<p>Hims said in a statement that the company &#8220;has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law.</p>
<p>&#8220;We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare.&#8221;</p>
<p>A Lilly spokesperson said the company applauded the FDA action. &#8220;For years, compounders have been putting patients at risk by unlawfully mass-producing knockoff drugs using substandard ingredients from illicit foreign suppliers and selling them without clinical evidence that they’re safe or even work. Patients deserve better, and we look forward to decisive action by FDA, other regulators, and law enforcement.”</p>
<p>Compounding, in which pharmacies mix ingredients for specialized medicines or to copy a drug but at different dosages, has flourished as Americans chase cheaper prices for drugs.</p>
<p>The practice is legal under the Federal Food, Drug and Cosmetic Act in certain circumstances, like when prescribed by a physician to address patient side effects or during a drug shortage.</p>
<p>Hims&#8217; compounded drug is not FDA-approved and has not gone through clinical trials to prove efficacy.</p>
<p>The FDA&#8217;s enforcement actions against Hims could include sending a warning letter, pursuing a court injunction or conducting an administrative seizure of products, said Joanne Hawana, a member at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</p>
<p>The agency would need the help of the Justice Department to pursue an injunction, as it lacks independent litigation authority, Hawana said.</p>
<p>The FDA&#8217;s statements suggest that &#8220;this announcement by Hims, to the government, is concerning enough that they decided they’re going to escalate,&#8221; Hawana said.</p>
<p>Thus far, the FDA&#8217;s actions on weight-loss drugs have been limited to warning letters sent in the fall of 2025 to combat misleading direct-to-consumer advertising and marketing.</p>
<p>Commissioner Marty Makary said in a statement on Friday that the agency will &#8220;use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns.&#8221;</p>
<p>The health regulator said that, in promotional materials, companies cannot claim that non-FDA-approved compounded products are generic versions or the same as drugs approved by FDA.</p>
<p>It added that &#8220;they also cannot state compounded drugs use the same active ingredient as the FDA-approved drugs or that compounded drugs are clinically proven to produce results for the patient.&#8221;</p>
<p>(Reporting by Siddhi Mahatole in Bengaluru and Leah Douglas in Washington; additional reporting by Amina Niasse in New York; Editing by Alan Barona and David Gregorio)</p>

<script async src="https://www.instagram.com/embed.js"></script>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

Hims Stock Tumbles As FDA Targets Its Discounted Weight-Loss Drugs

Trump To Congress: You Run The Kennedy Center

Trump Weighs AI Oversight Order As MAGA Allies Sound Alarm

Disgraced Hollywood Mogul’s Latest Rape Trial Ends Without Verdict

Republicans Move To Wipe Out Democrat Seats In Louisiana, South Carolina

Chinese Agent Found Guilty In NYC ‘Secret Police Station’ Case

Tariff Ruling Faces Pushback As Trump Blasts ‘Radical Left Judges’

News

Health

Ozempic

Prescription Drugs

U.S.

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Evening Wire: Lebanon Ceasefire Begins & Murder-Suicide Rocks VA | 4.16.26

The Pendragon Cycle

Menu

— News —

Hims Stock Tumbles As FDA Targets Its Discounted Weight-Loss Drugs